ProChon Biotech

Orthopedic biotech company Histogenics raises $34 million

Histogenics Corp. brought in more than $34 million in equity and debt financing after its acquisition of fellow Bay State firm ProChon Biotech Ltd. The two companies merged in an all-stock deal that brings ProChon CEO Patrick O’Donnell into the Histogenics corner office. O’Donnell told MassDevice.com last week that a deal has been in the works […]

By MassDevice Staff

MedCity Influencers

ProChon Biotech touts BioCart cartilage regeneration implant results

ProChon Biotech Ltd. touted the results of a study on knee cartilage defect patients treated with its BioCart system.

By MassDevice Staff

With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?

Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.